Advertisement
KYTX vs VNDA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYTX is a Buy and VNDA is a Hold.
KYTX sees its Stochastic Oscillator ascends from oversold territory
On October 28, 2026, the Stochastic Oscillator for KYTX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 33 instances where the indicator left the oversold zone. In 30 of the 33 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where KYTX's RSI Indicator exited the oversold zone, 17 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on KYTX as a result. In 45 of 52 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for KYTX just turned positive on October 27, 2026. Looking at past instances where KYTX's MACD turned positive, the stock continued to rise in 20 of 24 cases over the following month. The odds of a continued upward trend are 83%.
Following a +11.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where KYTX advanced for three days, in 121 of 135 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
KYTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for KYTX entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. KYTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.118) is normal, around the industry mean (3.162). P/E Ratio (-1.942) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
VNDA's RSI Oscillator slumps oversold zone
The RSI Indicator for VNDA moved into overbought territory on October 30, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where VNDA advanced for three days, in 155 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
VNDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VNDA as a result. In 71 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for VNDA turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 38 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for VNDA entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.041) is normal, around the industry mean (3.162). P/E Ratio (-0.817) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (1.378) is also within normal values, averaging (439.647).
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. VNDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
VNDA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 98 | |
PRICE GROWTH RATING 1..100 | 81 | |
P/E GROWTH RATING 1..100 | 17 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| KYTX | VNDA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 89% | 3 days ago 88% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 80% |
| Momentum ODDS (%) | 3 days ago 87% | 3 days ago 75% |
| MACD ODDS (%) | 3 days ago 83% | 3 days ago 79% |
| TrendWeek ODDS (%) | 3 days ago 85% | 3 days ago 77% |
| TrendMonth ODDS (%) | 3 days ago 89% | 3 days ago 76% |
| Advances ODDS (%) | 5 days ago 90% | 4 days ago 64% |
| Declines ODDS (%) | 3 days ago 88% | 7 days ago 74% |
| BollingerBands ODDS (%) | 3 days ago 88% | 3 days ago 82% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 79% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KYTX’s FA Score shows that 1 FA rating(s) are green while VNDA’s FA Score has 1 green FA rating(s).
- KYTX’s FA Score: 1 green, 4 red.
- VNDA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KYTX’s TA Score shows that 6 TA indicator(s) are bullish while VNDA’s TA Score has 4 bullish TA indicator(s).
- KYTX’s TA Score: 6 bullish, 2 bearish.
- VNDA’s TA Score: 4 bullish, 4 bearish.
Price Growth
KYTX (@Biotechnology) experienced а +5.19% price change this week, while VNDA (@Biotechnology) price change was -5.49% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.20%. For the same industry, the average monthly price growth was -14.01%, and the average quarterly price growth was -15.33%.
Reported Earning Dates
KYTX is expected to report earnings on Nov 11, 2026.
VNDA is expected to report earnings on Feb 10, 2027.
Industries' Descriptions
@Biotechnology (+0.20% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
KYTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IMNM could also see price increases.
| Ticker / NAME | Correlation To KYTX | 1D Price Change % | ||
|---|---|---|---|---|
| KYTX | 100% | -3.08% | ||
| IMNM - KYTX | 60% Loosely correlated | -0.44% | ||
| FDMT - KYTX | 58% Loosely correlated | -6.89% | ||
| VYGR - KYTX | 49% Loosely correlated | -2.27% | ||
| KURA - KYTX | 49% Loosely correlated | -2.84% | ||
| TSHA - KYTX | 48% Loosely correlated | -2.13% | ||
More | ||||
VNDA and
Correlation & Price change
A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with DYN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then DYN could also see price increases.
| Ticker / NAME | Correlation To VNDA | 1D Price Change % | ||
|---|---|---|---|---|
| VNDA | 100% | -6.42% | ||
| DYN - VNDA | 40% Loosely correlated | -2.05% | ||
| IVF - VNDA | 40% Loosely correlated | -10.46% | ||
| ARVN - VNDA | 38% Loosely correlated | -0.51% | ||
| EDIT - VNDA | 37% Loosely correlated | -8.87% | ||
| KYTX - VNDA | 37% Loosely correlated | -3.08% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SH | 32.86 | 0.60 | +1.86% |
| ProShares Short S&P500 (SH) | |||
| VTEB | 48.88 | 0.18 | +0.37% |
| Vanguard Tax-Exempt Bond ETF (VTEB) | |||
| DHLX | 14.03 | -0.08 | -0.59% |
| Diamond Hill Large Cap Concentrated ETF (DHLX) | |||
| USEP | 41.89 | -0.41 | -0.97% |
| Innovator U.S. Equity Ultra Buffer ETF - September (USEP) | |||
| STXX | 21.12 | -4.03 | -16.04% |
| Tradr 2X Long STX Daily ETF (STXX) | |||